BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26099343)

  • 1. Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?
    Laberko A; Gennery AR
    Expert Rev Clin Immunol; 2015; 11(7):785-8. PubMed ID: 26099343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning.
    Bhattacharya D; Rossi DJ; Bryder D; Weissman IL
    J Exp Med; 2006 Jan; 203(1):73-85. PubMed ID: 16380511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell differentiation and IL-21 response in
    Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
    Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
    White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
    Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients.
    Liu A; Vosshenrich CA; Lagresle-Peyrou C; Malassis-Seris M; Hue C; Fischer A; Di Santo JP; Cavazzana-Calvo M
    Blood; 2006 Aug; 108(4):1123-8. PubMed ID: 16614244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
    Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
    J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
    Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
    Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for profound T-cell deficiency (combined immunodeficiency).
    Roifman CM
    Immunol Allergy Clin North Am; 2010 May; 30(2):209-19. PubMed ID: 20493397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation.
    Dvorak CC; Hung GY; Horn B; Dunn E; Oon CY; Cowan MJ
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1125-1133. PubMed ID: 18804042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the immune system in severe combined immunodeficiency mice reconstituted with transferred fetal liver cells.
    Wakabayashi A; Eishi Y; Nakamura K
    J Med Dent Sci; 1997 Mar; 44(1):21-9. PubMed ID: 9385039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
    Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
    Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed onset of (severe) combined immunodeficiency (S)CID (T-B+NK+): complete IL-7 receptor deficiency in a 22 months old girl.
    Rossberg S; Schwarz K; Meisel C; Holzhauer S; Kühl J; Ebell W; Wahn V; von Bernuth H
    Klin Padiatr; 2009; 221(6):339-43. PubMed ID: 19890784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.